Geometry Dash APK Hill Climb Racing APK
45.8 F
New York
Thursday, February 25, 2021

CytoDyn Inc (OTCMKTS:CYDY) Stock Hits 7-Month High on Registration News

Must read

Ozop Energy Solutions Inc (OTCMKTS:OZSC) Looks Energized in 2021

There have been some remarkable rallies in the stock market in recent weeks and one of the more eye-catching ones has been...

Sun Pacific Holding Corp (OTCMKTS:SNPW) Stock Rockets and Crashes. What’s Next?

Sometimes certain stocks move in a big way without any development or news and although it remains a mystery for investors, it...

Artificial Intelligence Technology Solutions (OTCMKTS: AITX) Moves Up Quickly On Solid Volume

The artificial intelligence industry has grown at a remarkable pace over the past half a decade or so and over the coming...

Ozop Energy Solutions Inc (OTCMKTS:OZSC) Remains Volatile: Stock in Focus

Those who are looking to discover stocks that may have made big moves over the course of the past week could consider...

In the past year or so, many biotech companies have come into focus among investors due to their work on vaccines and treatments to tackle the coronavirus pandemic.

One such stock is that of the biotech company CytoDyn Inc (OTCMKTS:CYDY) and this week it is back in focus after a key announcement from the company on Monday.

Major Triggers

On Monday CytoDyn announced that it has chosen Chiral Pharma Corp with the task of registering its leronlimab coronavirus treatment product named Vyrologix in the Philippines.

The registration is going to be done under the provisions of a licensed physician’s request for Compassionate Special Permit (CSP). The treatment is going to be provided to patients for a fee.

It is a significant development for CytoDyn and the market recognized that as well. The stock soared on Monday after the announcement and delivered gains of as much as 29%. CytoDyn further noted that it is going to make as many as 100000 doses available to Chiral Pharma from its reserves for sales in the Philippines. However, that is not all.

The company also announced that it shared the results of several studies into Vyrologix as a treatment for COVID 19 patients with doctors, regulators and healthcare executives in the Philippines.

The sales of the product will start as soon as Chiral Pharma is able to get the CSP approval for it and it goes without saying that it could prove to be a major coup for CytoDyn. However, in addition to this news, there was another development with regards to the company that investors ought to keep in mind.

According to a filing at the Delaware Chancery Court this past week, the management and investors at CytoDyn agreed on a settlement with regards to a stockholder derivative lawsuit. It is another positive for the company and could even prove to be a boost for the stock as well.

Disclaimer: We hold no position in CYDY stock

Latest article

Blockchain Technologies Ltd (OTCMKTS:HVBTF) Makes A Stunning Move on Blockchain Optimism

The cryptocurrency boom has sustained for many months now and it anything; it is expected to continue in the future.

Enzolytics Inc (OTCMKTS:ENZC) In Focus: Regains It’s Momentum

One of the most notable gainers over the course of the past months has been the Enzolytics Inc stock. While it is...

Alpine 4 Technologies Ltd (OTCMKTS:ALPP) Looks to Maintain Critical Momentum

Stocks that make massive gains over a reasonable period of time cannot hope to maintain them forever. At some point, a correction...

Medmen Enterprises Inc (OTCMKTS:MMNFF) Pulls Back From Highs as Buzz Cools Off

Among the sectors which have bounced back in 2021, the cannabis sector is one of considerable interest since it had been in...

Green Thumb Industries Inc (OTCMKTS:GTBIF) Trades Near All-Time High: What Next?

After having been in the dumps for more than a year, the cannabis sector has managed to make a remarkable comeback. Investors...